Press Releases

Date	Title	PDF Version
Aug 28, 2014	Alexion to Present at Investor Conferences
Aug 25, 2014	Alexion Initiates Multinational Registration Trial of Eculizumab for the Prevention of Delayed Graft Function (DGF) after Kidney Transplantation
Aug 13, 2014	Researchers to Present New Data on Asfotase Alfa in Pediatric Patients with Hypophosphatasia at the American Society for Bone and Mineral Research 2014 Annual Meeting
Aug 01, 2014	European Commission Grants Orphan Drug Designation to Soliris® (eculizumab) for the Treatment of Patients with Myasthenia Gravis (MG)
Jul 24, 2014	Alexion Reports Second Quarter 2014 Results
Jul 24, 2014	European Medicines Agency Accepts Marketing Authorization Application for Asfotase Alfa as a Treatment for Patients with Hypophosphatasia
Jul 16, 2014	Alexion Announces the Appointments of David R. Brennan, M. Michele Burns and Christopher J. Coughlin to Its Board of Directors
Jul 10, 2014	Alexion Pharmaceuticals to Report Second Quarter 2014 Results on Thursday, July 24, 2014
Jun 23, 2014	Alexion and Cincinnati Children's Launch Rare Disease Innovation Fund
Jun 17, 2014	FDA Grants Orphan Drug Designation to Soliris® (eculizumab) for the Treatment of Patients with Myasthenia Gravis (MG)

Search